Beyond Celiac is the leading trusted resource on celiac disease. We are available and qualified to speak to the press on a variety of topics including, but not limited to:
Celiac disease as a serious genetic autoimmune disease
Health equity in celiac disease
Celiac disease patient advocacy and patient stories
The need for treatments beyond the gluten-free diet
The latest in celiac disease research/science/drug development
Non-GI symptoms of celiac disease
Connection to other autoimmune diseases
Growth of the gluten-free market, gluten-free labeling
If you are a member of the media, such as a journalist, blogger, etc., and want to know more about Beyond Celiac, including our research program, Science Plan, patient stories, and more, please contact Bailey Arman at [email protected].
For more information on Beyond Celiac, celiac disease and the gluten-free diet:
Beyond Celiac, the leading catalyst for a cure for celiac disease, today announces the creation of Beyond Celiac Investments (BCI), an investment program to accelerate the development of treatments and a cure for celiac disease by leveraging the speed and scale of venture capital and capital markets.
Beyond Celiac is pleased to announce the appointment of Debra Silberg, MD, PhD, FACG, as its new Chief Scientific Officer (CSO)
Beyond Celiac is presenting a Celiac Community Summit on Saturday, Sept. 30, 2023, at the Hyatt Regency in Old Greenwich, Conn., to provide celiac disease patients with the latest information on this serious autoimmune disease. The Summit features panels of expert speakers and vendors including a keynote address from NBC Today Show Co-host and Meteorologist Dylan Dreyer for a day of learning and sharing best practices.
Beyond Celiac and the Society for the Study of Celiac Disease award Shayna Coburn, PhD, of Children’s National Hospital, the 2023 Early Career Research Award
Beyond Celiac drives awareness of health inequities in diagnosis of celiac disease